Schizophrenia.
D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002491:Central Nervous System Agents / Q000009:adverse effects / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy*
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D002491:Central Nervous System Agents; D003692:Delayed-Action Preparations